Abstract

The quantitative structure–activity relationship (QSAR) of the novel 4-aminopyrimidine-5-carbaldehyde oxime derivatives as effective and selective inhibitors of potent VEGFR-2 was studied. A suitable set of the molecular descriptors was calculated, and the most impressive descriptors were subsequently selected using genetic algorithm (GA) variable selection approach. To construct robust models, the GA was combined with multiple linear regression and support vector machine, respectively, as GA-MLR and GA-SVM. The predictive quality of the QSAR model was examined for an external set of six compounds, randomly chosen out of 32 compounds in the original data set. The accuracy of the proposed models was further confirmed using cross-validation, validation through an external test set and Y-randomization approaches. Based on the selected descriptors, we have identified some key features in the 4-aminopyrimidine-5-carbaldehyde oxime derivatives that are responsible for potent VEGFR-2 inhibitory activity. The analyses may be used to design more potent 4-aminopyrimidine-5-carbaldehyde oxime derivatives and predict their activities prior to synthesis.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.